2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Louis B. Nabors, MD, of University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases.
Louis B. Nabors, MD, professor, University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases. For decades, as treatment for patients with brain metastases, physicians mainly relied on neurosurgery and radiation, and there were limited systemic therapy options.
Today, there is an increasing amount of systemic therapy options, says Nabors. These therapies have clearly demonstrated activity in metastatic disease in the central nervous system, he adds.
Research continues to focus on further developing these opportunities to better understand how to deploy systemic therapies in these patients. This will be a major goal over the next several years, he concludes.
Related Content: